(Des-His1,Glu9)-Glucagon (1-29) amide (human, rat, porcine) lacks the initial histidine and central glutamate, reshaping charge distribution along the chain. The amidated C-terminus further stabilizes the peptide backbone. Researchers apply this analog to interrogate key positions involved in conformational control and receptor binding. Its cross-species sequence enhances comparative peptide studies.
CAT No: G16012
CAS No:110084-95-2
Synonyms/Alias:110084-95-2;(Des-His1,Glu9)-Glucagon (1-29) amide (human, rat, porcine);(Des-His1,Glu9)-Glucagon (1-29) amide (human, rat, porcine) H-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-NH2;H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LE;Des-His 1-[Glu9]Glucagon Amide;[des-His1, Glu9]-Glucagon amide;MFCD00080353;H-Ser-gln-gly-thr-phe-thr-ser-glu-tyr-ser-lys-tyr-leu-asp-ser-arg-arg-ala-gln-asp-phe-val-gln-trp-leu-met-asn-thr-nh2;BDBM50098563;AKOS024456992;DA-59552;FD108767;PD076236;[des-His1, Glu9]-Glucagon amide, >=97% (HPLC);(D-His(Bzl)6)-LHRH (1-7) (free acid) Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-OH;Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Leu-Met-Asn-Thr-NH2 ([DesHis1, Glu9]Glucagon amide);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.